Mingyu Chen, M.D., Ph.D.
Associate Professor
To see if Mingyu Chen is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Specialties
Pathology - Molecular
Pathology - Hematopathology
Department
Locations and Contact
Additional Numbers
Physician Referrals
Clinical Interests
Dr. Chen's clinical interests include: Hematopathology- lymphoma, leukemia, flow cytometry, bone marrow transplant and diagnostic molecular pathology, Pulmonary pathology, and GI-liver pathology.
Research/Academic Interests
Dr. Chen's research interests include: Sickle cell disease, thrombosis, and vascular biology, Molecular pathogenesis of lymphoma and leukemia, tumor immunology and GVHD, Viral infections and cancergenesis.
Division
Anatomic Pathology
Center/Program Affiliation
Medical School
M.D., Peking University Health Science Center, Beijing, China 1992
Other School
Ph.D., Kyoto University, Kyoto Japan 2001
Internship
Pathology and Lab Medicine, UC San Diego Medical Center, San Diego CA 2005
Residency
Pathology and Lab Medicine, Loma Linda University Hospital, Loma Linda CA 2009
Fellowship
Pathology, City of Hope Medical Center, Duate CA 2010
International Society Hematology Presentation Award, 2014
Faculty Teaching Award of Department of Pathology UC Davis Medical Center, 2013
Mirsoian A, Boucklaka MN, Sckisel GD, Chen M, Pai CS, Maverakis,E, Spencer RG. Fishbein KF, Siddiqui S, Monjazeb AM, Martin B, Maudsley S, Longo DL, Blazar BR, Taub DD, and Murphy WJ. Adiposity as a Principal Component of Lethal Cytokine Storm Following Immunotherapy in Aged Mice. J Exp Med. 2014 Nov 17;211(12):2373-83.
Canter RJ, Ames E, Mac S, Grossenbacher SK, Chen M, Li CS, Borys D, Smith RC, Tellez J, Sayers TJ, Monjazeb AM, Murphy WJ. Anti-Proliferative but not Anti-Angiogenic Tyrosine Kinase Inhibitors Enrich for Cancer Stem Cells in Soft Tissue Sarcoma. BMC Cancer 2014 Oct 10;14(1):756.
Pai CC, Chen M, Mirsoian A, Grossenbacher SK, Tellez J, Ames E, Sun K, Blazar BR, Murphy WJ, Mehrdad A. Treatment of Chronic Graft versus Host Disease with Bortezomib. Blood. 2014 Sep 4;124(10):1677-88.
Pai CC, Hsiao HH, Sun K, Chen M, Hagino T, Tellez J, Mall C, Blazar BR, Monjazeb A, Abedi M, Murphy WJ. Therapeutic benefit of bortezomib on acute GVHD is tissue specific and is associated with IL-6 levels. Biol Blood Marrow Transplant. 2014 Jul 23. pii: S1083-8791(14)00448-50.
Alvarez M, Bouchlaka MN, Sckisel GD, Sungur CM, Chen M, Murphy WJ. J Immunol. 2014 Jul 7. pii: 1400034. Increased Antitumor Effects Using IL-2 with Anti-TGF-β Reveals Competition between Mouse NK and CD8 T Cells. J Immunol. 2014 Aug 15;193(4):1709-16.
Chen M, Abedi M. Atypical lymphocytosis and cold agglutinin hemolytic anemia associated with monoclonal gammopathy in HIV-infected patient with marrow involvement by diffuse large B-cell lymphoma. Blood, 2013 Nov 28;122(23):3711.
Chen M, Green R. Circulating plasma cells with Russell bodies in osteroslerotic myeloma. Blood 2013 122:160
Chen M, Olson K. Colonic graft-versus-host disease (GVHD) manifesting as eosinophilic colitis following autologous hematopoietic stem cell transplantation. Blood. 2013 May 16;121(20):4020.
Sungur CM, Tang-Feldman YJ, Ames E, Alvarez M, Chen M, Longo DL, Pomeroy C, Murphy WJ. Murine natural killer cell licensing and regulation by T regulatory cells in viral responses. Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7401-6.
Bouchlaka M Sckisel G, Chen M,, Mirsoan A, Zamora A, Monjazeb A, Longo D, Blazar BR, Taub DD, Murphy WJ. Aging Predisposes to Acute Pro-inflammatory Cytokine Storm-Induced Pathologies Following Systemic Immune Stimulation. J Exp Med. 2013 Oct 21;210(11):2223-37.